Is LDTCW or MRK a better dividend investment in 2026?

LDTCW currently yields 52631.58% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: LDTCW offers higher current income.

What is the dividend yield difference between LDTCW and MRK?

LDTCW has a forward dividend yield of 52631.58% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 52628.82 percentage points.

Home › Compare › LDTCW vs MRK

LDTCW vs MRK: Dividend Comparison 2026

LDTCW yields 52631.58% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LDTCW wins by $7.986841824948223e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LDTCW

● Live price

52631.58%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.986841824948223e+23M

Annual income

$795,710,146,136,258,500,000,000,000,000.00

Full LDTCW calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — LDTCW vs MRK

📍 LDTCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LDTCW	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LDTCW + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LDTCW pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LDTCW

Annual income on $10K today (after 15% tax)

$4,473,684.21/yr

After 10yr DRIP, annual income (after tax)

$676,353,624,215,819,700,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, LDTCW beats the other by $676,353,624,215,819,700,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LDTCW + MRK for your $10,000?

LDTCW: 50%MRK: 50%

100% MRK50/50100% LDTCW

Portfolio after 10yr

$3.9934209124741116e+23M

Annual income

$397,855,073,068,129,200,000,000,000,000.00/yr

Blended yield

99.63%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LDTCW

No analyst data

Altman Z

-59.5

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LDTCW buys

MRK buys

Politician	Chamber	Ticker	Type	Amount	Date
Josh Gottheimer	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2026-02-04
Michael McCaul	🏢 House	$MRK	▼ Sell	$15,001 - $50,000	2026-01-13
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-12-19
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-12-18
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-11-13
Ro Khanna	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-29
Val Hoyle	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-23
Marjorie Taylor Greene	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-28
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-08-14
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-05

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLDTCWMRK

Forward yield	52631.58% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$7.986841824948223e+23M	$56.8K ✓
Annual income after 10y	$795,710,146,136,258,500,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$7.984889844873965e+23M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: LDTCW vs MRK ($10,000, DRIP)

Year	LDTCW Portfolio	LDTCW Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$5,273,858	$5,263,157.89	$11,206	$366.19	+$5.26M → LDTCW
2	$2,599,768,898	$2,594,125,870.51	$12,650	$502.35	+$2599.76M → LDTCW
3	$1,197,907,458,231	$1,195,125,705,509.77	$14,407	$694.19	+$1197907.44M → LDTCW
4	$515,939,295,120,189	$514,657,534,139,881.20	$16,585	$967.82	+$515939295.10M → LDTCW
5	$207,713,959,232,287,460	$207,161,904,186,508,860.00	$19,342	$1,363.89	+$207713959232.27M → LDTCW
6	$78,168,139,314,512,790,000	$77,945,885,378,134,250,000.00	$22,913	$1,947.19	+$78168139314512.77M → LDTCW
7	$27,497,709,268,240,953,000,000	$27,414,069,359,174,423,000,000.00	$27,662	$2,823.89	+$27497709268240952.00M → LDTCW
8	$9,042,154,837,977,321,000,000,000	$9,012,732,289,060,305,000,000,000.00	$34,159	$4,173.35	+$9042154837977321472.00M → LDTCW
9	$2,779,473,232,302,745,600,000,000,000	$2,769,798,126,626,110,300,000,000,000.00	$43,337	$6,308.80	+$2.7794732323027456e+21M → LDTCW
10	$798,684,182,494,822,400,000,000,000,000	$795,710,146,136,258,500,000,000,000,000.00	$56,776	$9,798.13	+$7.986841824948223e+23M → LDTCW

LDTCW vs MRK: Complete Analysis 2026

LDTCW — Stock

LeddarTech Holdings Inc. provides AI-based fusion and perception software solutions for advanced driver assistance solutions and autonomous driving applications in Canada. It offers LeddarVision, a raw sensor fusion and perception platform for automotive and off-road industrial vehicles. The company was founded in 2007 and is based in Quebec City, Canada.

Full LDTCW Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this LDTCW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LDTCW vs SCHD LDTCW vs JEPI LDTCW vs O LDTCW vs KO LDTCW vs MAIN LDTCW vs JNJ LDTCW vs ABBV LDTCW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.